Sigma aims to “restore Amcal to its rightful place” following Chemist Warehouse merger More than 20 My Chemist outlets are set to transition to Sigma Healthcare’s Amcal banner as part …

Boosting uptake of 60-day prescriptions offers greater savings for patients and taxpayers, the Grattan Institute says  Uptake of 60-day dispensing is falling short of expectations with experts from the Grattan …

HELP debt relief welcomed, but pharmacy students will still face placement poverty, NAPSA warns  Pharmacy students are set to continue to face difficult decisions after the government opted not to …

Budget boosts ACCC funding to strengthen enforcement of the Franchising Code of Conduct  Labor will invest $12 million over the next four years to “support and protect small businesses”, the …

Budget measures aimed at improving access to primary care and cheaper medicines are being lauded, but pharmacy workforce issues persist  Confirmation that the maximum Pharmaceutical Benefits Scheme (PBS) co-payment will …

Treasurer announces increased funding for RUM and Take Home Naloxone programs alongside push for “even cheaper medicines” in pre-election budget The Commonwealth will provide $784.6 million over the next four …

Self-doubt is holding pharmacists back from embracing full scope of practice, one of Australia’s first prescribing pharmacists says  Pharmacists working to their full scope of practice will be “transformational” for …

Government’s plan to lower the maximum PBS general co-payment to $25 will reduce stress, patient says  Labor’s move to reduce the Pharmaceutical Benefits Scheme (PBS) general co-payment to $25 from …

Accelerated and simplified price disclosure measures have created “perverse outcomes”, the program’s architect says  Government policy designed to secure cheap prices for medicines needs to be updated, former Department of …

Pharmacy owners get four years’ warning to embrace full scope of practice or risk missing out on funding in the 9CPA  Pharmacies that do not implement new services as the …

Boosting uptake of biosimilars will require practitioner change and a policy rethink, GBMA chair says  Australia is “underdone on penetration in the market” when it comes to uptake of biosimilar medications, …

Empowering pharmacists to work to their full scope to fix Australia’s healthcare crisis, Guild president says  Pharmacists working to their full scope of practice “it not a revolution… it is …